Review
Sep 2026
Innovative Therapies for HER2-altered Non-Small Cell Lung Cancer: a Narrative Review.
A narrative review summarizes the clinicopathological features of HER2-altered NSCLC, critically evaluates emerging HER2-targeted therapies, and discusses future treatment directions.
Oscar Arrieta, E. Caballé-Pérez, L. Cabrera-Miranda et al.
· Critical reviews in oncology... · 0 citations